About Genomics sector in San Diego, United States
The Genomics sector in San Diego, United States comprises 235 companies, including 145 funded companies having collectively raised $7.22B in venture capital money and private equity. Out of these, 91 are Series A+ funded.
Genomics sector in San Diego, United States has seen 48 acquisitions and 8 IPOs. This represents almost 23.8% of all such companies - which is higher than the 5.0% exit rate of tech companies in general.
This sector includes companies engaged in the detection, structural and functional characterization, measurement, manipulation, and modification of an organism's genes and its products.
Genomics sector is also known as Genetic Analysis.
Companies primarily developing or manufacturing technologies, platforms, reagents, kits, products, services, or solutions that involve the measurement, analysis, modification, or manipulation of an organism's DNA or RNA Companies developing tools, technologies, platforms or products which do not directly involve nucleic acid analysis. Also excludes traditional molecular biology companies; generic reagent companies; traditional and integrated CROs; biopharma companies not focused on genomics as a therapeutic modality, or molecules which do not target the genetic material; traditional or phenotype-based plant or animal breeding companies; microbial tech companies that do not use genetically modified microbial strains etc.
Top Genomics Companies in San Diego, United States
There are 235 Genomics startups in San Diego, United States which include Illumina, DermTech, Ambrx, Aspen Neuroscience, Poseida Therapeutics. Out of these, 145 startups are funded, with 91 having secured Series A+ funding.
Over the past 10 years, an average of 5 new companies have been launched annually. Notably, several of these startups have been founded by alumni of Stanford University, Massachusetts Institute of Technology and Harvard University.
Here is the list of top Genomics startups in San Diego, United States
1. Illumina
Developer of technologies for analysis of genetic variation and function. The company provides laboratory instruments, kits, and reagents for research, drug development, and the development of molecular tests. The product categories include gene panel and array finder, microarray kits, clinical research, and IVD products.
Key facts about Illumina
- Founded Year: 1993
- Location: San Diego (United States)
- Stage: Public
- Total Funding till date: $28M
- Investors: State Farm, Chevron Technology Ventures and 32 Others
- Latest Funding Round: Grant (prize money), Jan 01, 2020, $*****
- Tracxn Score: 73/100 What is this?
- Competitors Rank: 2 of 622 Competitors
2. DermTech
DermTech develops qPCR assays and diagnostic aides for skin samples collected non-invasively to detect melanoma and skin cancer. It has a proprietary technology that allows skin 'biopsies' to be taken by applying an adhesive patch on the patient's skin. This patch can able to take cells present in the outermost skin layer and then analyze them for gene expression levels.
Key facts about DermTech
- Founded Year: 1996
- Location: San Diego (United States)
- Stage: Acquired
- Total Funding till date: $24.4M
- Investors: RTW Investments, Van Herk Groep and 3 Others
- Latest Funding Round: Post IPO, Mar 13, 2020, $*****
- Tracxn Score: 68/100 What is this?
- Competitors Rank: 3 of 176 Competitors
3. Ambrx
Developer of Antibody-drug conjugates to treat cancers, metabolic disorders, and cardiovascular disorders. The company has developed Engineered Precision Biologics (EPBs) by using proprietary genetic code technology to produce antibody-drug conjugates (ADCs) and immuno-oncology conjugates (IOCs) for treating cancers. The product pipeline includes ARX788 an anti-HER2 ADC currently being studied in breast cancer, gastric cancer, and other solid tumors, ARX517 for prostate cancer, and more. They have developed immuno-oncology conjugates for NASH, heart failure, and prostate cancer
Key facts about Ambrx
- Founded Year: 2003
- Location: San Diego (United States)
- Stage: Acquired
- Total Funding till date: $346M
- Investors: Glynn Capital, Fidelity Investments and 23 Others
- Latest Funding Round: Series E, Nov 09, 2020, $*****
- Tracxn Score: 65/100 What is this?
- Competitors Rank: 80 of 4,283 Competitors
Provider of genomic-based personalized pluripotent stem cell therapy. It offers regenerative cell treatment like dopaminergic neurons for Parkinson's disease and other neurological disorders. It maintains the genetic-based quality control to avoid the mutation of cells used for therapy.
Key facts about Aspen Neuroscience
- Founded Year: 2018
- Location: San Diego (United States)
- Stage: Series C
- Total Funding till date: $339M
- Investors: Orbimed, Revelation Partners and 22 Others
- Latest Funding Round: Series C, Nov 20, 2025, $*****
- Tracxn Score: 64/100 What is this?
- Competitors Rank: 24 of 786 Competitors
Developer of gene therapies for treating cancer and liver orphan disease by using gene-editing technologies. It is developing CAR-T and gene therapy products for cancer and orphan diseases. Poseida uses its genome engineering capabilities for effectively silencing target genes or inserting therapeutic genes. Proprietary tools include piggyBac DNA Modification System, CRISPR, TALEN, and Footprint-Free Gene Editing System, which are clean (synthetic and virus-free) and can be surgically precise.
Key facts about Poseida Therapeutics
- Founded Year: 2015
- Location: San Diego (United States)
- Stage: Acquired
- Total Funding till date: $324M
- Investors: Fidelity Investments, Novartis and 12 Others
- Latest Funding Round: Post IPO, Aug 07, 2023, $*****
- Tracxn Score: 64/100 What is this?
- Competitors Rank: 19 of 882 Competitors
Companies founded year-on-year in the Genomics sector in San Diego
19 Genomics startups in San Diego were founded in 2017 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | - |
2025 | - |
2024 | 1 |
2023 | 1 |
2022 | 2 |
2021 | 8 |
2020 | 5 |
2019 | 4 |
2018 | 15 |
2017 | 19 |
Stage-wise distribution of Genomics sector companies in San Diego
Out of the total 235 Genomics companies in San Diego, 145 have secured funding. Among them, 91 have reached Series A or higher, and 75 to Series B or beyond.
Founded - 235
Funded - 145
Series A+ - 91
Series B+ - 75
Series C+ - 70
Company Stage | No. of companies |
|---|---|
Founded | 235 |
Funded | 145 |
Series A+ | 91 |
Series B+ | 75 |
Series C+ | 70 |
Let us walk you through our Sectors and other offerings
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Funding Trends in the Genomics sector in San Diego
Total funding year-on-year in the Genomics sector in San Diego
The Genomics sector in San Diego saw a total funding of more than $5.06B in the last 10 years. The most amount of funding was in 2020 at more than $1.05B.
- Total Funding
Year | Total Funding |
|---|---|
2025 | $295M |
2024 | $140M |
2023 | $519M |
2022 | $363M |
2021 | $761M |
2020 | $1.05B |
2019 | $699M |
2018 | $482M |
2017 | $492M |
Recent Funding Rounds in Genomics in San Diego
In the year 2025, till November 2025, Genomics companies in San Diego have raised $295M in equity funding across 9 rounds.
In the same period last year (i.e. till July 2024), Genomics companies in San Diego had raised $17.9M across 4 rounds.
So, 2025 has seen a 1542.75% rise in funding in Genomics companies in San Diego as compared to 2024.
Here are some recent, important funding rounds in Genomics companies in San Diego:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series C | 6310 | Nov 20, 2025 | ||
Series A | 1000 | Nov 05, 2025 | - | |
Series A | 1982 | Oct 03, 2025 | - | |
Series C | 7382 | Jun 26, 2025 | ||
Series B | 2824 | Jun 18, 2025 |
Top Investors in Genomics in San Diego
Illumina is the top investor in Genomics companies in San Diego based on number of companies invested.
Here are some top investors in Genomics companies in San Diego:
Investor | Location | Top Portfolio Companies |
|---|---|---|
San Diego (United States) | ||
San Diego (United States) | ||
Basel (Switzerland) | ||
Princeton (United States) | ||
San Diego (United States) |
M&A activity in Genomics sector in San Diego
In the year 2025, till June 2025, 3 acquisitions happened in Genomics sector in San Diego. Last year, in 2024, a total of 3 acquisitions happened in Genomics sector in San Diego.
Here are some recent, important acquisitions in Genomics sector in San Diego:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Jun 27, 2025 | ||
Business Acquisition | Apr 30, 2025 | ||
Business Acquisition | Mar 31, 2025 | ||
Business Acquisition | Dec 23, 2024 | ||
Business Acquisition | Nov 26, 2024 |
Acquisition trends in Genomics sector in San Diego
Here are the acquisition trends in Genomics sector in San Diego:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | - |
2025 | 3 |
2024 | 3 |
2023 | 3 |
2022 | 3 |
2021 | 12 |
2020 | 4 |
2019 | 6 |
2018 | 2 |
2017 | 1 |
IPOs in Genomics in San Diego
In the year 2023, till November 2023, 2 IPOs happened in Genomics sector in San Diego.
Here are some recent, important IPOs in Genomics sector in San Diego:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Nov 24, 2023 | Euronext Exchange (Euronext) | |
Jul 21, 2023 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jun 18, 2021 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jun 18, 2021 | New York Stock Exchange (NYSE) | |
May 28, 2021 | National Association of Securities Dealers Automated Quotations (NASDAQ) |
Colleges which produce the most Genomics companies in San Diego
Companies founded by alumni from top colleges in the Genomics in San Diego
Most number of Genomics startups in San Diego have been founded by alumni from Stanford University, Massachusetts Institute of Technology and Harvard University.
College | No. of companies |
|---|---|
Stanford University | 6 |
Massachusetts Institute of Technology | 5 |
Harvard University | 4 |
University of California (Berkeley) | 3 |
University of California (Los Angeles) | 3 |
Columbia University | 2 |
Duke University | 2 |
University of Cambridge | 2 |
University of Pennsylvania | 2 |
University of Toronto | 2 |
Total funding in Genomics companies founded by alumni from top colleges in San Diego
In the last 10 years, Stanford University graduates' Genomics companies in San Diego have raised the most funding among top colleges. Harvard University alumni are second, and King’s College London alumni are third.
College | Total Funding |
|---|---|
Stanford University | $358M |
Harvard University | $349M |
King’s College London | $332M |
University of Pennsylvania | $286M |
IIT Kharagpur | $160M |
University of California (Los Angeles) | $74.3M |
Yale University | $73.6M |
Massachusetts Institute of Technology | $50.9M |
University of Chicago | $32M |
Tsinghua University | $29.2M |
Top News in Genomics in San Diego
•
ADARx Doses First Subject in Phase III Trial of ADX-324 for HAEClinical Trials Arena•Oct 23, 2025•ADARx Pharmaceuticals
•
Actio Biosciences Announces U.S. FDA Clearance & Fast Track for ABS-1230 Epilepsy TreatmentBusiness Wire•Jul 30, 2025•Actio Biosciences
•
•
•
•
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s DiseaseBusiness Wire•Jan 08, 2025•Aspen Neuroscience, Mytos
•
ClearNote's cancer blood test chosen for NCI Vanguard study.Business Wire•Jan 07, 2025•ClearNote Health, National Cancer Institute
•
•
•
